Earnings Feed
Start Free
CASI Pharmaceuticals, Inc.·4

May 26, 4:12 PM ET

Salisbury Franklin Cary jr 4

4 · CASI Pharmaceuticals, Inc. · Filed May 26, 2022

Insider Transaction Report

Form 4
Period: 2022-05-25
CASI Pharmaceuticals, Inc.CASI
Salisbury Franklin Cary jr
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2022-05-25+388,387→ 388,387 total
    Exercise: $0.47Exp: 2032-05-25→ Common Stock (388,387 underlying)
Footnotes (1)
  • [F1]Stock option award will vest ratably quarterly to the end of the year.
Signature
/s/ Alexander A. Zukiwski, attorney-in-fact for Franklin Salisbury, Jr.|2022-05-26

Documents

2 files